AAIC 2025 Abstract
Cerebrospinal fluid NPTXR changes and relationships with β‐amyloid load and metabolism by PET in Alzheimer’s disease
Study in peopleBiomarkers
Abstract
Background: Neuronal pentraxin receptor (NPTXR) has been identified as a cerebrospinal fluid (CSF) biomarker associated with synaptic pathology, demonstrating its significant correlation with progressive cognitive impairment in Alzheimer’s disease (AD).
